Impact Biomedical Files Form F-4 Registration Statement for Proposed Merger with Zoar Limited

Filing content

Impact Biomedical filed a Form F-4 registration statement with the SEC regarding its proposed merger with Zoar Limited. The completion of the transaction remains subject to SEC effectiveness, stockholder approval, and other closing conditions.